Submitting Orders Sample Clauses

Submitting Orders. You can start trading by clicking on the respective button in the Investment Pocket,Crypto Pocket or Precious Metals Pocket. You can place buy orders for all the financial instruments listed in the Investment Pocket, Crypto Pocket respectively the Precious Metals Pocket by selecting one of these financial instruments. You will then be provided with further details of the transaction and the individual "Key Information Document on fractional shares", respectively the "Key Information Document on fractional coins" respectively the “Key Information Document on fractional precious metals”. CME provides price offers to purchase the respective financial instruments. By clicking on the respective button to buy you not only accept the offer to purchase the relevant financial instrument at the specified price, but also place an order to transfer the corresponding amount to CME upon completion of the purchase. Please note that the offer to buy the financial instrument at the displayed price is valid only for a short period of time In the Investment Pocket respectively Crypto Pocket respectively Precious Metals Pocket You can also sell the purchased financial instruments. A sale is possible only to CME. By clicking on the respective button to buy or sell a financial instrument the respective contract is concluded. Please note that You can only submit orders to buy or sell financial instruments when the exchange/market is open for the relevant instruments and once an order is submitted by You, neither You nor Vivid Invest will be able to cancel the order, unless in unforeseen events. Vivid Invest will transmit Your order as a messenger to CME and has herewith fulfilled its respective duty under this agreement with You. Please be aware that We will not transmit any orders if We note that You are undertaking any fraudulent behavior or suspected market abuse, manipulation of the Vivid Invest App or the order execution system, or abusing any latency that might exist in the Vivid Invest App.
Sample 1Sample 2See All (4)
AutoNDA by SimpleDocs
Submitting Orders. (a) The Customer may submit an Order for the purchase of Products through any means permitted by Pittella from time to time (which may include by telephone, email, letter or through the Website). Every Order must include any information Pittella may reasonably require, including details of the relevant Products to be ordered (including any applicable product codes and selected finishes for the Products), the Customer’s requested collection or delivery date and address (if applicable).
Sample 1Sample 2Sample 3
Submitting Orders. All orders must be submitted to the Company within 2 days from the date of the sale. In the case of a paper order, the order must be entered / processed via the REP's back office order submission process to be received by the Company. The REP is responsible to make copies of all paper orders and keep them on file if needed. Misuse or abuse of customer money or credit cards will be prosecuted to the fullest extent of the law.
Sample 1
Submitting Orders. To order Products, Reseller must submit to an Authorized Distributor an Order that sets forth the details for the ordered Products and identifies the Business Entity. The Distributor will process all Reseller Orders with Mist. Mist will have no obligation to supply any Hardware or Mist Dashboard services unless and until an order has been accepted by an Authorized Distributor, and subsequently by Mist.
Sample 1
Submitting Orders. You can submit orders for all financial instruments displayed in the Investment Pocket by selecting a displayed financial instrument. For each "buy" or "sell" order You intend to submit You will receive a quote within the Vivid Invest App. The quote is indicative only. Quotes for buying and selling in relation to an individual financial instrument may differ (so-called "spread"). Once You have clicked on the "buy" or "sell" button for a specific financial instrument, you will be provided with the details of the transaction. If you confirm these, Your order will be considered "submitted". Please note that once an order is submitted by You, neither You nor Vivid Invest will be able to cancel the order, unless in unforeseen events. Vivid Invest will transmit Your order as a messenger to CME and has herewith fulfilled its respective duty under this agreement with You. Please be aware that We will not transmit any orders if We note that You are undertaking any fraudulent behavior or suspected market abuse, manipulation of the Vivid Invest App or the order execution system, or abusing any latency that might exist in the Vivid Invest App.
Sample 1
Submitting Orders. You are obliged to date and indicate the time of receipt of all orders you receive from your customers and to transmit promptly all orders to us in time to provide for processing at the price next determined after receipt by you, in accordance with the Prospectuses. You are not to withhold placing with us orders received from any customers for the purchase of shares. You shall not purchase shares through us except for the purpose of covering purchase orders already received by you, or for your bona fide investment.
Sample 1
Submitting Orders. (a) Every Order by the Customer for the supply of Products must be submitted in writing in the manner required by Frosty Boy from time to time and include such information as Frosty Boy may require, including details of the relevant Products to be ordered (and any applicable product codes) and the Customer’s requested Supply Terms and collection/delivery date.
Sample 1
AutoNDA by SimpleDocs
Submitting Orders. 4.21. The Client is entitled to submit Orders in person, by phone, fax, e-mail (only scanned documents), post, via Internet Bank and Home-Banking.
Sample 1
Submitting Orders. 1. Only a Customer with an active User Account may place Orders. Placing an Order is possible only after logging in to the User Account.
Sample 1

Related to Submitting Orders

  • Aggregating Orders On occasions when the Manager deems the purchase or sale of a security to be in the best interest of the Fund as well as other advisory clients of the Manager, the Manager, to the extent permitted by applicable laws and regulations, may, but shall be under no obligation to, aggregate the securities to be so sold or purchased in order to obtain the most favorable price or lower brokerage commissions and efficient execution. In such event, allocation of securities so purchased or sold, as well as the expense incurred in the transaction, will be made by the Manager in the manner it considers to be most equitable and consistent with its fiduciary obligations to the Fund and its other clients.

  • Submission of Orders Each person desiring to purchase Shares in the Offering will be required to complete and execute a subscription eligibility form provided by the Company to each Dealer for use in connection with the Offering (the “Eligibility Form”) and to deliver to the Dealer such completed and executed Eligibility Form together with a check or wire transfer (“instrument of payment”) in the amount of such person’s purchase, which must be at least the minimum purchase amount set forth in the Prospectus. Those persons who purchase Shares will be instructed by the Dealer to make their instruments of payment payable to or for the benefit of “Dividend Capital Diversified Property Fund Inc.” Purchase orders received and processed by the Company prior to the close of the New York Stock Exchange (generally, 4:00 p.m. Eastern time; the “close of business”) on any business day will be executed at the price per share of the class of shares being purchased calculated at the end of such business day plus, for Class A shares only, applicable selling commissions, in accordance with the procedures described in the Prospectus. Purchase orders received and processed after the close of business on any business day, or on a day that is not a business day, will be executed at the price per share of the class of shares being purchased calculated at the end of the next business day plus, for Class A shares only, applicable selling commissions, in accordance with the procedures described in the Prospectus. Subscribers may not submit an initial purchase order until at least five (5) business days after the date on which the subscriber receives a copy of the Prospectus. If the Dealer receives an Eligibility Form or instrument of payment not conforming to the foregoing instructions, the Dealer shall return such Eligibility Form and instrument of payment directly to such subscriber not later than the end of the next business day following its receipt. Eligibility Forms and instruments of payment received by the Dealer which conform to the foregoing instructions shall be transmitted for deposit pursuant to one of the methods described in this Section II. Transmittal of received investor funds will be made in accordance with the following procedures: Where, pursuant to the Dealer’s internal supervisory procedures, internal supervisory review is conducted at the same location at which Eligibility Forms and instruments of payment are received from subscribers, Eligibility Forms and instruments of payment will be transmitted by the end of the next business day following receipt by the Dealer for deposit to Dividend Capital Diversified Property Fund Inc. as set forth in the Eligibility Form or as otherwise directed by the Company. Where, pursuant to the Dealer’s internal supervisory procedures, final and internal supervisory review is conducted at a different location, Eligibility Forms and instruments of payment will be transmitted by the end of the next business day following receipt by the Dealer to the office of the Dealer conducting such final internal supervisory review (the “Final Review Office”). The Final Review Office will in turn, by the end of the next business day following receipt by the Final Review Office, transmit such Eligibility Forms and instruments of payment for deposit to Dividend Capital Diversified Property Fund Inc. as set forth in the Eligibility Form or as otherwise directed by the Company.

  • Conflicting Orders or Instructions If the Financial Institution receives conflicting orders or instructions from the Secured Party and the Grantor or any other Person, the Financial Institution will follow the orders or instructions of the Secured Party and not the Grantor or such other Person.

  • FDA As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (“FDA”) under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (“FDCA”) that is manufactured, packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a “Pharmaceutical Product”), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration, investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company's knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company.

  • Review Procedures The Parties agree to jointly conduct a review, sampling transactions of the incidents managed under this Agreement. Findings that are inconsistent with the normal or accepted way of doing business will be reconciled on a case by case basis. Any decision to further examine records will be considered on a case by case basis and appropriate follow up action agreed upon by all agencies involved. Payment for Protection Services (use if appropriate) Geographic, Statewide or Sub-Geographic (local) operating plans and procurement documents or agreement will establish billing procedures for Fee Basis Protection Services.

  • Orders Any order placed by a Participating Entity or Purchasing Entity for a product and/or service available from this Master Agreement shall be deemed to be a sale under (and governed by the prices and other terms and conditions) of the Master Agreement unless the parties to the order agree in writing that another contract or agreement applies to such order.

  • Entitlement Orders If at any time the Securities Intermediary shall receive any Entitlement Order from the Assignee-Secured Party with respect to any 2017-A Collateral Account, the Securities Intermediary shall comply with such Entitlement Order without further consent by the Transferor, the Initial Secured Party or any other Person. If at any time the Assignee-Secured Party notifies the Securities Intermediary in writing that the Lien of the Indenture has been released and all Issuer Obligations have been paid, the Securities Intermediary shall thereafter comply with Entitlement Orders with respect to each 2017-A Collateral Account from the Initial Secured Party without further consent by the Transferor or any other Person. Notwithstanding anything to the contrary contained herein, if at any time the Securities Intermediary receives conflicting orders or instructions from the Assignee-Secured Party and the Initial Secured Party, the Securities Intermediary will follow the orders or instructions of the Assignee-Secured Party and not the Initial Secured Party.

  • Normal order of application Except as any Finance Document may otherwise provide, any sums which are received or recovered by any Creditor Party under or by virtue of any Finance Document shall be applied:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!